1. Home
  2. RVLV vs CRNX Comparison

RVLV vs CRNX Comparison

Compare RVLV & CRNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Revolve Group Inc.

RVLV

Revolve Group Inc.

HOLD

Current Price

$28.33

Market Cap

1.7B

ML Signal

HOLD

Logo Crinetics Pharmaceuticals Inc.

CRNX

Crinetics Pharmaceuticals Inc.

HOLD

Current Price

$50.53

Market Cap

4.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RVLV
CRNX
Founded
2003
2008
Country
United States
United States
Employees
N/A
N/A
Industry
Catalog/Specialty Distribution
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.7B
4.1B
IPO Year
2019
2018

Fundamental Metrics

Financial Performance
Metric
RVLV
CRNX
Price
$28.33
$50.53
Analyst Decision
Buy
Buy
Analyst Count
13
11
Target Price
$26.42
$71.00
AVG Volume (30 Days)
958.4K
1.1M
Earning Date
11-04-2025
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
35.78
N/A
EPS
0.78
N/A
Revenue
$1,195,039,000.00
$1,535,000.00
Revenue This Year
$8.95
$425.31
Revenue Next Year
$6.42
$943.50
P/E Ratio
$36.69
N/A
Revenue Growth
9.24
47.74
52 Week Low
$16.80
$24.10
52 Week High
$39.58
$60.25

Technical Indicators

Market Signals
Indicator
RVLV
CRNX
Relative Strength Index (RSI) 70.51 72.28
Support Level $25.48 $46.49
Resistance Level $29.32 $49.29
Average True Range (ATR) 1.21 1.96
MACD 0.40 0.41
Stochastic Oscillator 84.41 94.31

Price Performance

Historical Comparison
RVLV
CRNX

About RVLV Revolve Group Inc.

Revolve Group Inc is an emerging e-commerce retailer, selling women's dresses, handbags, shoes, beauty products, and incidentals across its marketplace properties, Revolve and FWRD. The platform is built to suit the "next-generation customer," emphasizing mobile commerce, influencer marketing, and occupying an aspirational but attainable luxury niche. With $1.1 billion in 2024 net sales, the firm sits just outside the top 30 apparel retailers (by sales) in the U.S, but has consistently generated robust top-line growth as the industry continues to favor digital channels. Revolve generates approximately 18% of sales from private-label offerings, while focusing on building an inventory of distinctive products from emerging fashion brands with less than $10 million in annual sales.

About CRNX Crinetics Pharmaceuticals Inc.

Crinetics Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. Its products include Paltusotine and Atumelnant.

Share on Social Networks: